Understanding the immune correlates of protection in infected individuals with a mild form of COVID-19 versus those with the severe form of the disease is essential for therapeutic interventions or vaccine design.

  • Funded by Emergent Ventures Fast Grants
  • Total publications:0 publications

Grant number: unknown

Grant search

Key facts

  • Disease

    COVID-19
  • start year

    -99
  • Known Financial Commitments (USD)

    $0
  • Funder

    Emergent Ventures Fast Grants
  • Principal Investigator

    Dr. Shokrollah Elahi
  • Research Location

    Canada
  • Lead Research Institution

    University of Alberta
  • Research Priority Alignment

    N/A
  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Disease pathogenesis

  • Special Interest Tags

    N/A

  • Study Type

    Unspecified

  • Clinical Trial Details

    N/A

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

Understanding the immune correlates of protection in infected individuals with a mild form of COVID-19 versus those with the severe form of the disease is essential for therapeutic interventions or vaccine design.